Return on Net Operating Assets Chart

View Return on Net Operating Assets for PPCB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Return on Net Operating Assets Data

View and export this data back to 2012. Start Trial.
Date Value
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
June 30, 2025 --
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --
June 30, 2024 --
March 31, 2024 --
December 31, 2023 --
September 30, 2023 --
June 30, 2023 --
March 31, 2023 --
December 31, 2022 --
September 30, 2022 --
June 30, 2022 --
March 31, 2022 --
December 31, 2021 --
September 30, 2021 --
June 30, 2021 --
March 31, 2021 --
December 31, 2020 --
September 30, 2020 --
June 30, 2020 --
March 31, 2020 --
Date Value
December 31, 2019 --
September 30, 2019 --
June 30, 2019 --
March 31, 2019 --
December 31, 2018 --
September 30, 2018 --
June 30, 2018 --
March 31, 2018 --
December 31, 2017 --
September 30, 2017 --
June 30, 2017 --
March 31, 2017 --
December 31, 2016 --
September 30, 2016 --
June 30, 2016 --
March 31, 2016 --
December 31, 2015 --
September 30, 2015 --
June 30, 2015 --
March 31, 2015 --
December 31, 2014 --
September 30, 2014 --
June 30, 2014 --
March 31, 2014 --
December 31, 2013 --

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Immutep Ltd. --
CSL Ltd. --
Ceryvyn Therapeutics Ltd. --
Mesoblast Ltd. --
Actinogen Medical Ltd. --

Return on Net Operating Assets Related Metrics